Published in BMC Res Notes on July 21, 2011
The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord (2012) 1.06
Cross-cultural variation in symptom perception of hypoglycemia. J Midlife Health (2013) 1.05
Hypoglycemia: The neglected complication. Indian J Endocrinol Metab (2013) 1.01
Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control. Cardiovasc Diabetol (2013) 1.00
Hypoglycaemic events in patients with type 2 diabetes in the United Kingdom: associations with patient-reported outcomes and self-reported HbA1c. BMC Endocr Disord (2013) 0.86
Is hypoglycemia fear independently associated with health-related quality of life? Health Qual Life Outcomes (2014) 0.82
The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation. BMC Health Serv Res (2017) 0.78
Participatory surveillance of diabetes device safety: a social media-based complement to traditional FDA reporting. J Am Med Inform Assoc (2013) 0.77
Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes (2015) 0.76
The Impact of Diabetes-Related Complications on Preference-Based Measures of Health-Related Quality of Life in Adults with Type I Diabetes. Med Decis Making (2016) 0.75
Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China. PLoS One (2016) 0.75
Health-related quality of life and utility values associated to hypoglycemia in patients with type 1 diabetes mellitus treated in the Brazilian Public Health System: a multicenter study. Diabetol Metab Syndr (2017) 0.75
Social implications of tight glycemic control. Can Fam Physician (2012) 0.75
Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data. Diabetes Ther (2014) 0.75
Self-reported frequency, severity of, and awareness of hypoglycemia in type 2 diabetes patients in Turkey. PeerJ (2016) 0.75
Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine. J Multidiscip Healthc (2013) 0.75
The Real-Life Effectiveness and Care Patterns of Diabetes Management Study for Balkan Region (Slovenia, Croatia, Serbia, Bulgaria): A Multicenter, Observational, Cross-Sectional Study. Diabetes Ther (2017) 0.75
Practical Approaches to Diagnosing, Treating and Preventing Hypoglycemia in Diabetes. Diabetes Ther (2017) 0.75
EuroQol: the current state of play. Health Policy (1996) 27.78
US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care (2005) 9.89
Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care (2005) 8.80
Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes. Diabetologia (2002) 6.00
Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care (2004) 4.57
Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care (1988) 3.86
Hypoglycaemia in Type 2 diabetes. Diabet Med (2008) 3.00
A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns (2007) 2.42
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin (2005) 1.97
The economic and quality of life impact of hypoglycemia. Eur J Health Econ (2005) 1.61
Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab (2008) 1.57
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr Med Res Opin (2006) 1.44
Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res (2007) 1.39
Symptoms of hypoglycaemia in people with diabetes. Diabet Med (2001) 1.17
Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France. Diabetes Obes Metab (2008) 1.12
Patient-reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain. Diabetes Obes Metab (2009) 1.00
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (2009) 3.74
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. Am J Kidney Dis (2013) 2.89
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses. Clin Pharmacol Ther (2005) 2.85
Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes. J Clin Endocrinol Metab (2006) 2.64
Efficacy and safety of the coadministration of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia. Eur Heart J (2005) 2.52
Effect of supplemental folic acid in pregnancy on childhood asthma: a prospective birth cohort study. Am J Epidemiol (2009) 2.44
Relationship between coronary artery remodeling and plaque vulnerability. Circulation (2002) 2.35
Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol (2002) 2.19
Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust (2007) 2.03
Health care and productivity costs associated with diabetic patients with macrovascular comorbid conditions. Diabetes Care (2009) 1.97
Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes. Diabetes Res Clin Pract (2007) 1.81
A review of neuraxial epidural morbidity: experience of more than 8,000 cases at a single teaching hospital. Anesthesiology (2007) 1.80
Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update (2004) 1.73
Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes. Diabetes Care (2011) 1.70
Burden of illness associated with lower urinary tract symptoms including overactive bladder/urinary incontinence. Urology (2009) 1.69
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res (2004) 1.65
Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes. BMC Endocr Disord (2010) 1.60
The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology (2013) 1.56
Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol (2004) 1.51
Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res (2002) 1.42
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. J Clin Pharmacol (2008) 1.40
Oxidative damage to extracellular matrix and its role in human pathologies. Free Radic Biol Med (2008) 1.40
Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study. Curr Med Res Opin (2009) 1.39
Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics (2005) 1.36
Quantification of protein modification by oxidants. Free Radic Biol Med (2009) 1.34
Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials. Curr Med Res Opin (2008) 1.28
Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis. BMC Endocr Disord (2008) 1.28
Dietary composition of pregnant women is related to size of the baby at birth. J Nutr (2004) 1.23
Roles of tyrosine-rich precursor glycoproteins and dityrosine- and 3,4-dihydroxyphenylalanine-mediated protein cross-linking in development of the oocyst wall in the coccidian parasite Eimeria maxima. Eukaryot Cell (2003) 1.23
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene (2003) 1.23
Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochim Biophys Acta (2006) 1.22
A comparison of dexmedetomidine versus conventional therapy for sedation and hemodynamic control during carotid endarterectomy performed under regional anesthesia. Anesth Analg (2006) 1.20
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis. Cardiovasc Diabetol (2013) 1.17
Diet around conception and during pregnancy--effects on fetal and neonatal outcomes. Reprod Biomed Online (2006) 1.16
Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study. Curr Med Res Opin (2011) 1.16
The role of lifestyle modification in polycystic ovary syndrome. Trends Endocrinol Metab (2002) 1.14
Photo-oxidation of proteins. Photochem Photobiol Sci (2011) 1.14
Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum (2005) 1.12
Requirements for superoxide-dependent tyrosine hydroperoxide formation in peptides. Biochem J (2004) 1.11
Singlet oxygen-mediated protein oxidation: evidence for the formation of reactive side chain peroxides on tyrosine residues. Photochem Photobiol (2002) 1.11
Early pregnancy loss following assisted reproductive technology treatment. Hum Reprod (2002) 1.11
Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study. Curr Med Res Opin (2008) 1.10
Hypochlorous acid-mediated protein oxidation: how important are chloramine transfer reactions and protein tertiary structure? Biochemistry (2007) 1.07
Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I. Arterioscler Thromb Vasc Biol (2010) 1.06
Actions of ultraviolet light on cellular structures. EXS (2006) 1.05
Multinational Internet-based survey of patient preference for newer oral or injectable Type 2 diabetes medication. Patient Prefer Adherence (2010) 1.04
Estimation of resource utilization associated with osteoporotic hip fracture and level of post-acute care in China. Curr Med Res Opin (2007) 1.04
Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin (2009) 1.03
Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. Curr Med Res Opin (2012) 1.02
The vinyl ether linkages of plasmalogens are favored targets for myeloperoxidase-derived oxidants: a kinetic study. Biochemistry (2008) 1.02
Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia. J Am Coll Cardiol (2006) 1.01
Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem Res Toxicol (2005) 1.01
Radical chemistry of epigallocatechin gallate and its relevance to protein damage. Arch Biochem Biophys (2003) 1.01
Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients. Curr Med Res Opin (2012) 1.01
Hypochlorite-induced damage to DNA, RNA, and polynucleotides: formation of chloramines and nitrogen-centered radicals. Chem Res Toxicol (2002) 1.00
What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach. Chem Res Toxicol (2009) 0.99
The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol (2004) 0.99
Kinetic analysis of the reactions of hypobromous acid with protein components: implications for cellular damage and use of 3-bromotyrosine as a marker of oxidative stress. Biochemistry (2004) 0.99
The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages. Biochem J (2010) 0.98
Hypothiocyanous acid reactivity with low-molecular-mass and protein thiols: absolute rate constants and assessment of biological relevance. Biochem J (2009) 0.97
Protein-bound kynurenine is a photosensitizer of oxidative damage. Free Radic Biol Med (2004) 0.97
Oxidation and inactivation of SERCA by selective reaction of cysteine residues with amino acid peroxides. Chem Res Toxicol (2007) 0.96
Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols. Biochem J (2006) 0.96
Hypochlorite-mediated fragmentation of hyaluronan, chondroitin sulfates, and related N-acetyl glycosamines: evidence for chloramide intermediates, free radical transfer reactions, and site-specific fragmentation. J Am Chem Soc (2003) 0.95
Food and nutrient intakes of 9-month-old infants in Adelaide, Australia. Public Health Nutr (2009) 0.95
Hypochlorous acid-mediated oxidation of lipid components and antioxidants present in low-density lipoproteins: absolute rate constants, product analysis, and computational modeling. Chem Res Toxicol (2003) 0.95
Photo-oxidation of cells generates long-lived intracellular protein peroxides. Free Radic Biol Med (2003) 0.95
Evaluation of pharmacokinetic parameters and dipeptidyl peptidase-4 inhibition following single doses of sitagliptin in healthy, young Japanese males. Br J Clin Pharmacol (2011) 0.94
Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes. Patient Prefer Adherence (2013) 0.94
Hypothiocyanous acid is a more potent inducer of apoptosis and protein thiol depletion in murine macrophage cells than hypochlorous acid or hypobromous acid. Biochem J (2008) 0.94
Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia. Am Heart J (2007) 0.94
Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations. Biochem Pharmacol (2009) 0.93
Removal of amino acid, peptide and protein hydroperoxides by reaction with peroxiredoxins 2 and 3. Biochem J (2010) 0.93
Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch Biochem Biophys (2002) 0.93
Markers of protein oxidation: different oxidants give rise to variable yields of bound and released carbonyl products. Free Radic Biol Med (2004) 0.93
Tryptophan-derived ultraviolet filter compounds covalently bound to lens proteins are photosensitizers of oxidative damage. Free Radic Biol Med (2007) 0.92
A survey of patient preferences for oral antihyperglycemic therapy in patients with type 2 diabetes mellitus. Diabetes Ther (2015) 0.92
Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care (2004) 0.92
Oxidation of DNA, proteins and lipids by DOPA, protein-bound DOPA, and related catechol(amine)s. Toxicology (2002) 0.92
Singlet-oxygen-mediated amino acid and protein oxidation: formation of tryptophan peroxides and decomposition products. Free Radic Biol Med (2009) 0.92
Guanine-specific DNA damage induced by gamma-irradiated histone. Biochem J (2005) 0.92
Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids. Free Radic Res (2012) 0.92
Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database. Curr Med Res Opin (2010) 0.91
Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res (2009) 0.91
Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan. Matrix Biol (2009) 0.91
Changes in affect and state anxiety across an in vitro fertilization/intracytoplasmic sperm injection cycle. Fertil Steril (2009) 0.91
Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Curr Med Res Opin (2015) 0.90
Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques. Biochem J (2003) 0.90
Detection and characterisation of radicals in biological materials using EPR methodology. Biochim Biophys Acta (2013) 0.90
Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates. Biochem J (2004) 0.89
Superoxide radicals can act synergistically with hypochlorite to induce damage to proteins. FEBS Lett (2002) 0.89